The opioid use epidemic has affected millions of Americans, and overdose fatalities are now the leading cause of death for Americans under 50. Meanwhile, harmful prescriber restrictions limit who can access lifesaving addiction medicine.
But the Mainstreaming Addiction Treatment (MAT) Act (HR 1384 / S 445) can help save lives. The MAT would increase access to lifesaving addiction medicine by eliminating the federal buprenorphine waiver — commonly called the X-waiver — that medical professionals must receive from the Drug Enforcement Administration to prescribe buprenorphine for the treatment of substance use disorder.
Take action today and urge your members of Congress to support MAT.